247 Hypoalbuminemia Is a Surrogate Biomarker of Poor Prognosis in Myelodysplastic Syndrome Even When Adjusted With Comorbidities

Post-transplant lymphoproliferative disease in heart and lung transplantation: Defining risk and prognostic factors

“…5 Hypoalbuminemia, a marker of systemic inflammation, systemic response to malignancy and a marker of low nutritional status, has also been shown to be a poor prognostic marker based on the Glasgow Prognostic Score, an inflammation-based prognosticator used in gastrointestinal, hepatic, lung and hematologic malignancies. [42][43][44] A complete response to initial therapy retained significance for favorable prognosis.…”